NZ Colorectal Oncology Research Review Issue 40

In this issue:
  -  Nivolumab + ipilimumab in MSH mCRC
  -  Post-colonoscopy CRC
  -  Diet-wide analyses for risk of CRC
  -  Single-round performance of CRC screening
  -  Optimal stopping ages for CRC screening
  -  Combining cetuximab with traditional chemotherapy
  -  Quality-adjusted survival with fruquintinib in mCRC
  -  Health-related quality of life associated with fruquintinib
  -  Disappearing colorectal liver metastases
  -  Total neoadjuvant therapy vs preoperative chemoradiotherapy

Please login below to download this issue (PDF)

Subscribe